Welgene Biotech Co., Ltd.(TW:6661)
NT$16.000.00 (0.00%)
TW:6661
Welgene Biotech Co., Ltd. financials statements
NT$16.00
At close:0.00 (0.00%)
Welgene Biotech Co., Ltd. (6661) Financial Statements
Welgene Biotech Co., Ltd. Financial Overview
Welgene Biotech Co., Ltd.'s market cap is currently NT$372.87M. The company's EPS TTM is NT$-0.07; its P/E ratio is -234.26; and it has a dividend yield of 0.80%. Welgene Biotech Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 375.94M | NT$ 322.55M | NT$ 280.55M | NT$ 321.90M | NT$ 312.65M |
| Gross Profit | NT$ 129.27M | NT$ 135.84M | NT$ 119.72M | NT$ 141.80M | NT$ 133.27M |
| Operating Income | NT$ 127.00K | NT$ -704.00K | NT$ -4.26M | NT$ 16.61M | NT$ 12.17M |
| EBITDA | NT$ 27.92M | NT$ 33.01M | NT$ 26.84M | NT$ 35.66M | NT$ 39.12M |
| Net Income | NT$ 1.33M | NT$ 1.11M | NT$ -2.65M | NT$ 9.55M | NT$ 13.70M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 269.03M | NT$ 228.19M | NT$ 197.83M | NT$ 218.36M | NT$ 224.26M |
| Total Assets | NT$ 622.19M | NT$ 528.25M | NT$ 548.16M | NT$ 435.71M | NT$ 424.54M |
| Total Debt | NT$ 226.03M | NT$ 129.83M | NT$ 154.35M | NT$ 51.19M | NT$ 23.84M |
| Net Debt | NT$ -6.00K | NT$ -43.66M | NT$ -33.78M | NT$ -107.40M | NT$ -175.92M |
| Total Liabilities | NT$ 336.12M | NT$ 232.50M | NT$ 247.89M | NT$ 131.76M | NT$ 114.47M |
| Stockholders' Equity | NT$ 281.30M | NT$ 287.91M | NT$ 292.03M | NT$ 303.76M | NT$ 309.86M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -6.08M | NT$ 51.27M | NT$ -28.10M | NT$ 24.57M | NT$ 6.87M |
| Operating Cash Flow | NT$ 35.27M | NT$ 56.08M | NT$ -366.00K | NT$ 51.43M | NT$ 11.25M |
| Investing Cash Flow | NT$ -35.74M | NT$ -45.19M | NT$ 6.00M | NT$ -67.99M | NT$ -10.34M |
| Financing Cash Flow | NT$ 51.31M | NT$ -25.52M | NT$ 23.91M | NT$ -24.61M | NT$ 38.52M |
Currency in TWD
